Director of Crispr Therapeutics Ag (NASDAQ:CRSP), Bolzon Bradley J Phd, sells 171,004 shares worth $26,424,505
According to Crispr Therapeutics Ag's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 09 07:54 PM, company Director, Bolzon Bradley J Phd disclosed selling 171,004 shares at a cost of $154.53. At the time of this transaction (Dec 07), this trade was worth $26,424,505 in total. As of Dec 07, Bolzon Bradley J Phd now owns 347,186 shares in total worth about $50,907,883.18.
For the last few recent trades made by Crispr Therapeutics Ag (NASDAQ:CRSP) Director, Bolzon Bradley J Phd, we have the following information:
- SEC Form 4 filing: Sep 18: Sold 3,035 shares at the rate of $86.87 per share. Total worth of this trade was $263,636. Total number of shares owned as of Sep 18 were 518,190
- SEC Form 4 filing: Sep 16: Sold 8,965 shares at the rate of $86.98 per share. Total worth of this trade was $779,777. Total number of shares owned as of Sep 16 were 521,225
- SEC Form 4 filing: Sep 14: Sold 1,155 shares at the rate of $84.89 per share. Total worth of this trade was $98,045. Total number of shares owned as of Sep 14 were 530,190
Posted by
George Daniels
on Thursday December 10 2020, 9:14 AM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
